[HTML][HTML] Myricetin: A review of the most recent research

X Song, L Tan, M Wang, C Ren, C Guo, B Yang… - Biomedicine & …, 2021 - Elsevier
Myricetin (MYR) is a flavonoid compound widely found in many natural plants including
bayberry. So far, MYR has been proven to have multiple biological functions and it is a …

The role of the CXCL12/CXCR4/CXCR7 chemokine axis in cancer

Y Shi, DJ Riese, J Shen - Frontiers in pharmacology, 2020 - frontiersin.org
Chemokines are a family of small, secreted cytokines which regulate a variety of cell
functions. The CXC motif chemokine ligand 12 (CXCL12) binds to CXC chemokine receptor …

Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment

WL Hwang, KA Jagadeesh, JA Guo, HI Hoffman… - Nature …, 2022 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal and treatment-refractory
cancer. Molecular stratification in pancreatic cancer remains rudimentary and does not yet …

Pharmacological properties and derivatives of shikonin—A review in recent years

C Guo, J He, X Song, L Tan, M Wang, P Jiang… - Pharmacological …, 2019 - Elsevier
Shikonin is the major bioactive component extracted from the roots of Lithospermum
erythrorhizon which is also known as “Zicao” in Traditional Chinese Medicine (TCM). Recent …

Single-cell transcriptomics of pancreatic cancer precursors demonstrates epithelial and microenvironmental heterogeneity as an early event in neoplastic progression

V Bernard, A Semaan, J Huang… - Clinical Cancer …, 2019 - aacrjournals.org
Purpose: Early detection of pancreatic ductal adenocarcinoma (PDAC) remains elusive.
Precursor lesions of PDAC, specifically intraductal papillary mucinous neoplasms (IPMNs) …

[HTML][HTML] Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy

P Sharma, M Otto - Bioactive Materials, 2024 - Elsevier
Cancer immunotherapy has gained momentum for treating malignant tumors over the past
decade. Checkpoint blockade and chimeric antigen receptor cell therapy (CAR-T) have …

CXCL12-CXCR4/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies

T Khare, M Bissonnette, S Khare - International journal of molecular …, 2021 - mdpi.com
Chemokines are chemotactic cytokines that promote cancer growth, metastasis, and
regulate resistance to chemotherapy. Stromal cell-derived factor 1 (SDF1) also known as …

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti–PD-L1 immunotherapy

Z Li, Y Wang, Y Shen, C Qian, D Oupicky, M Sun - Science advances, 2020 - science.org
Anti–programmed cell death 1 ligand 1 (PD-L1) therapy is extraordinarily effective in select
patients with cancer. However, insufficient lymphocytic infiltration, weak T cell–induced …

CXCL12/CXCR4 signal transduction in diseases and its molecular approaches in targeted-therapy

A Mousavi - Immunology Letters, 2020 - Elsevier
Chemokines are small molecules called “chemotactic cytokines” and regulate many
processes like leukocyte trafficking, homing of immune cells, maturation, cytoskeletal …

Stromal modulation and treatment of metastatic pancreatic cancer with local intraperitoneal triple miRNA/siRNA nanotherapy

Y **e, Y Hang, Y Wang, R Sleightholm, DR Prajapati… - ACS …, 2020 - ACS Publications
Nanomedicines achieve tumor-targeted delivery mainly through enhanced permeability and
retention (EPR) effect following intravenous (IV) administration. Unfortunately, the EPR effect …